Literature DB >> 510320

Investigation of accelerated metabolic function in small for gestational age infants.

H B von Stockhausen, M Struve.   

Abstract

Small for gestational age (SGA) infants are known to develop relatively mild transient hyperbilirubinaemia, especially in comparison with premature infants. This may be interpreted as an index of accelerated maturation of particular vital functions. In the present study 12 SGA infants, 12 appropriate for gestational age (AGA) infants, and 12 premature infants had 24 h urine collections under standardized conditions on the third day of life. Urinary excretion of D-glucaric acid and creatinine, which can be increased by drugs (e.g. phenobarbital), were estimated. Haematocrit and bilirubin were determined at the age of 72h. In the 3 groups, the SGA infants had the highest mean haematocrit (SGA = 0.58, AGA = 0.5, Prem = 0.561/1) and the lowest mean bilirubin (SGA = 6.3, AGA = 8.6, Prem = 11.1 mg/dl). Despite a comparatively small urine volume (SGA = 19.6, AGA = 28.3, Prem = 37.3 ml/kg), excretion of D-glucaric acid (SGA = 0.18, AGA = 0.11, Prem = 0.06 mumol/kg) and creatinine (SGA = 101.6, AGA = 79.6, Prem = 80.2 mumol/kg) was significantly higher in the SGA infants. While the results do not provide conclusive evidence, the increased excretion of glucaric acid and creatinine associated with mild transient hyperbilirubinaemia can be considered an indicator of metabolic differences in SGA infants.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 510320     DOI: 10.1007/bf00442433

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  35 in total

1.  Metabolism of d-glucuronolactone in mammalian systems. 2. Conversion of d-glucuronolactone into d-glucaric acid by tissue preparations.

Authors:  C A Marsh
Journal:  Biochem J       Date:  1963-04       Impact factor: 3.857

2.  Pharmacokinetics of acetaminophen in the human neonate: formation of acetaminophen glucuronide and sulfate in relation to plasma bilirubin concentration and D-glucaric acid excretion.

Authors:  G Levy; N N Khanna; D M Soda; O Tsuzuki; L Stern
Journal:  Pediatrics       Date:  1975-06       Impact factor: 7.124

3.  Lecithin-sphingomyelin ratios in amniotic fluid in normal and abnormal pregnancy.

Authors:  L Gluck; M V Kulovich
Journal:  Am J Obstet Gynecol       Date:  1973-02-15       Impact factor: 8.661

4.  Urinary D-glucaric acid assay by an improved enzymatic procedure.

Authors:  C J Simmons; M Davis; B Dordoni; R Williams
Journal:  Clin Chim Acta       Date:  1974-02-28       Impact factor: 3.786

Review 5.  Body composition in intrauterine growth retardation.

Authors:  G Cassady
Journal:  Pediatr Clin North Am       Date:  1970-02       Impact factor: 3.278

6.  [Effect of gestational age on icterus neonatorum in newborn infants with low birth weight].

Authors:  K Menzel; W Braun; G Völksch
Journal:  Helv Paediatr Acta       Date:  1972-11

7.  [Influence of phenobarbital on glucoronic acid excretion in newborns].

Authors:  G Zwacka; J Frenzel
Journal:  Dtsch Gesundheitsw       Date:  1972-08-31

8.  The effect of intra-partum and intra-uterine asphyxia on placental transfusion in premature and full-term infants.

Authors:  O Linderkamp; H T Versmold; K Messow-Zahn; W Müller-Holve; K P Riegel; K Betke
Journal:  Eur J Pediatr       Date:  1978-01-17       Impact factor: 3.183

9.  Assessment of plasma glutamyl transpeptidase activity and urinary D-glucaric acid excretion as indices of enzyme induction.

Authors:  D C Davidson; W B McIntosh; J A Ford
Journal:  Clin Sci Mol Med       Date:  1974-09

10.  An evaluation of urinary D-glucaric acid excretion during acute hepatitis in man.

Authors:  M Carrella; A D'Arienzo; G Manzillo; F De Ritis
Journal:  Am J Dig Dis       Date:  1978-01
View more
  1 in total

1.  Ponderal index as a predictor of neonatal morbidity in small for gestational age infants.

Authors:  J Kishan; A Y Elzouki; N A Mir; A M Faquih
Journal:  Indian J Pediatr       Date:  1985 Mar-Apr       Impact factor: 1.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.